Eco R1 Capital, Llc Insider Trades

Insider Trading History

Track insider trading activity for Eco R1 Capital, Llc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Atara Biotherapeutics
Atara Biotherapeutics ATRA
10% owner
Holding Value $15.9M 1,552,000 shares
Last Trade
May 07, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.74M 507,407 shares
$9.35
$10.27
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $389M 7,521,024 shares
Last Trade
May 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.5M 668,237 shares
$21.63
$51.67
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $389M 7,521,024 shares
Last Trade
May 05, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.5M 668,237 shares
$21.63
$51.67
Prothena plc
Prothena plc PRTA
Director
Holding Value $107M 11,584,280 shares
Last Trade
May 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$30.8M 1,062,736 shares
$29.02
$9.25
Prothena plc
Prothena plc PRTA
Director
Holding Value $107M 11,584,280 shares
Last Trade
May 05, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.8M 1,062,736 shares
$29.02
$9.25
Prothena plc
Prothena plc PRTA
10% owner
Holding Value $107M 11,584,280 shares
Last Trade
Jan 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.3M 300,000 shares
$37.50
$9.25
Prothena plc
Prothena plc PRTA
10% owner
Holding Value $0 0 shares
Last Trade
Jun 18, 2021 Sale (In The Money)Reported as In The Money on SEC Form 4.
$128k 2,500 shares
$51.01
$9.25
Prothena plc
Prothena plc PRTA
10% owner
Holding Value $104M 11,284,280 shares
Last Trade
Jun 18, 2021 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$12.8M 250,000 shares
$51.01
$9.25
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $389M 7,520,424 shares
Last Trade
May 04, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.84M 165,000 shares
$23.25
$51.67
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $380M 7,355,424 shares
Last Trade
May 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$485k 20,800 shares
$23.31
$51.67
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $379M 7,334,624 shares
Last Trade
Apr 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$827k 35,700 shares
$23.16
$51.67
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $377M 7,298,924 shares
Last Trade
Apr 27, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$805k 33,800 shares
$23.82
$51.67
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $375M 7,265,124 shares
Last Trade
Apr 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$331k 13,900 shares
$23.80
$51.67
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $375M 7,251,224 shares
Last Trade
Apr 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.34M 99,600 shares
$23.54
$51.67
Prothena plc
Prothena plc PRTA
10% owner
Holding Value $102M 11,034,280 shares
Last Trade
Mar 24, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.2M 875,000 shares
$25.40
$9.25
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $370M 7,151,624 shares
Last Trade
Mar 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.93M 531,000 shares
$18.70
$51.67
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $342M 6,620,624 shares
Last Trade
Mar 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$52.7M 2,777,800 shares
$18.97
$51.67
Prothena plc
Prothena plc PRTA
10% owner
Holding Value $94M 10,159,280 shares
Last Trade
Feb 24, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$238k 10,800 shares
$22.02
$9.25
AnaptysBio
AnaptysBio ANAB
10% owner
Holding Value $199M 3,842,824 shares
Last Trade
Feb 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$752k 29,500 shares
$25.48
$51.67
Prothena plc
Prothena plc PRTA
10% owner
Holding Value $93.9M 10,148,480 shares
Last Trade
Feb 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$935k 44,400 shares
$21.05
$9.25

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up